You are probably not making venture allocation decisions. Read this anyway, because investment trend data does something more directly useful for most business leaders: it functions as a proxy for market maturity and vendor credibility. When a vendor tells you quantum computing is commercially proven, the honest test is not their pitch deck. It is whether the capital, revenue, and named commercial engagements back that claim up independently. This is a market-context article, not investment advice, and I want that distinction on record before the numbers start.
Think of this as the equivalent of checking a supplier's credit rating before signing a contract, applied to an entire technology category rather than a single company. You would not evaluate a new vendor purely on their own sales pitch. You would look at who else is buying from them, how the category is trending, and whether independent analysts see the same growth the vendor claims to see. Quantum investment data lets you run that same check on the category as a whole, which is a faster and more reliable filter than assessing each individual vendor pitch from scratch.
The headline 2025 figures, precisely sourced
According to McKinsey's Quantum Technology Monitor 2026, published 10 June 2026, quantum technology start-ups raised $12.6 billion in 2025, more than six times the total raised in 2024. That is the single most consequential figure in this article, and it is worth sitting with rather than skimming past. A sixfold jump in a single year is not the kind of number that shows up in a mature, steadily-growing category. It is the kind of number that shows up at an inflection point, when a market moves from speculative interest to something closer to consensus among institutional allocators that the category is worth serious capital.
Quantum computing companies generated over $1 billion in revenue worldwide in 2025 on the same tracking, with McKinsey projecting growth to $4.4 billion by 2028. Per McKinsey's tracking, roughly 90 percent of 2025 investment was directed specifically to quantum computing, as distinct from quantum communication and quantum sensing, which tells you where the capital currently believes the nearest-term commercial return sits. That concentration is itself informative: if you are evaluating a vendor in the sensing or communication side of the quantum landscape rather than computing proper, the capital backing behind their category is meaningfully thinner, and that should adjust how much weight you give a growth projection from that part of the market. Cumulative global public investment in quantum technology, government and public-sector funding rather than private venture capital, stands at approximately $42 billion, per the same report. Treat that last figure as a scale indicator rather than a precise audited total; it is McKinsey's own tracking estimate, not a government-published sum.
What the longer-range projections mean, and what they don't
Here is the section where most coverage of this topic gets sloppy, so I will be deliberately careful. McKinsey's Quantum Technology Monitor 2026 cites two categories of longer-range figure, and they measure genuinely different things. The first is direct technology-sector market value: quantum technology's own market is estimated at $43 to 71 billion by 2035. The second is McKinsey's separate estimate that quantum computing could generate up to $2.7 trillion in economic value globally by 2035, a figure that captures the broader value created across every industry that adopts quantum applications, not the revenue of quantum vendors themselves. A pharmaceutical company saving years of development time through quantum-assisted molecular simulation contributes to the second figure without appearing in the first at all.
Do not add these two figures together, and be suspicious of anyone who does. A vendor citing "$2.7 trillion" to justify the size of their own addressable market is either confused about the distinction or hoping you will not check it. The direct market-value range, $43 to 71 billion, is the more relevant figure if you are sizing the quantum technology sector itself. The $2.7 trillion figure is the more relevant one if you are thinking about your own industry's exposure to quantum-enabled disruption or advantage, regardless of whether you ever buy anything from a quantum vendor directly.
Here is a concrete way to keep the two straight in a meeting where someone inevitably conflates them. Ask whether the figure being quoted describes revenue booked by a company that sells quantum hardware or software, or value created by a company that used quantum technology to do something else better. Airbus is a useful example precisely because it sits on the second side of that line: whatever value Airbus eventually captures from quantum-assisted materials or logistics work shows up in the $2.7 trillion economy-wide estimate, not in the $43 to 71 billion figure that describes the quantum vendors' own market. Keeping that distinction straight is not a pedantic exercise. It is the difference between correctly sizing an opportunity and being misled by a number that sounds bigger than it is because it is measuring something else entirely.
QSECDEF's Summer Bootcamp Session 9, "The Quantum Market Ecosystem," covers this investment and market landscape in full curriculum depth. See the full Summer Bootcamp structure.
What a business leader should actually track, going forward
Two tracks, moving on different clocks, and a business leader tracking only one is working from half the picture. The commercial track: over 300 companies, including Airbus, JPMorgan Chase, and Boehringer Ingelheim, are now actively working with quantum technology vendors on commercial challenges, per McKinsey's tracking. That is the number worth revisiting each time McKinsey publishes an updated Monitor, because it tells you whether commercial engagement is broadening beyond early-adopter sectors or plateauing. The regulatory track moves independently and, in 2026, moved fast: NIST finalised FIPS 203, 204, and 205 in August 2024, and the US federal government issued Executive Order 14412 and OMB Memorandum M-26-15 within two days of each other in June 2026, setting binding post-quantum migration deadlines for covered federal systems. Regulatory certainty of that kind is itself a factor shaping enterprise quantum investment decisions, separate from the commercial and venture figures above, which is why it belongs on your watch list even though it is not, strictly speaking, an investment figure at all.
One honest caveat to close on, because a sixfold jump in a single year invites overreading. Investment growth of this scale is consistent with the kind of inflection point seen in prior emerging-technology cycles once early commercial proof points start to accumulate. It is a leading indicator, not proof that quantum computing has already achieved commercial advantage at scale; the honest maturity picture, including where near-term applications genuinely outperform classical methods and where they currently do not, is covered directly in the commercial application side of this investment growth. The opportunity-cost argument this data feeds into for training budgets specifically, distinct from the security-spend argument made elsewhere on this site, is the subject of quantum computing training ROI: how to justify the budget line. For readers who want the full depth this article deliberately compresses, that is what Session 9 of the Bootcamp is for.
What I would actually do with this data, practically, is set a standing quarterly reminder rather than treating this article as a one-time briefing. McKinsey and comparable trackers update these figures on a roughly annual cycle, and the regulatory track above has already shown it can move meaningfully within a single quarter. A business leader who reads this once in September 2026 and never revisits it will be working from a stale picture by the time the next Monitor publishes. The two-track structure, commercial and regulatory, is designed to be re-checked, not memorised once.
